Cryoprecipitate AHF vs. fibrinogen concentrates for fibrinogen replacement in acquired bleeding patients - an economic evaluation.
about
Fibrinogen Early In Severe Trauma studY (FEISTY): study protocol for a randomised controlled trial.ADAMTS13 test and/or PLASMIC clinical score in management of acquired thrombotic thrombocytopenic purpura: a cost-effective analysis.Plasma Transfusion Demystified: A Review of the Key Factors Influencing the Response to Plasma Transfusion.Optimizing transfusion strategies in damage control resuscitation: current insights
P2860
Cryoprecipitate AHF vs. fibrinogen concentrates for fibrinogen replacement in acquired bleeding patients - an economic evaluation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Cryoprecipitate AHF vs. fibrin ...... ents - an economic evaluation.
@en
Cryoprecipitate AHF vs. fibrin ...... ents - an economic evaluation.
@nl
type
label
Cryoprecipitate AHF vs. fibrin ...... ents - an economic evaluation.
@en
Cryoprecipitate AHF vs. fibrin ...... ents - an economic evaluation.
@nl
prefLabel
Cryoprecipitate AHF vs. fibrin ...... ents - an economic evaluation.
@en
Cryoprecipitate AHF vs. fibrin ...... ents - an economic evaluation.
@nl
P2093
P2860
P50
P356
P1433
P1476
Cryoprecipitate AHF vs. fibrin ...... ents - an economic evaluation.
@en
P2093
C K Okerberg
J Schwartz
M L Kilgore
P2860
P304
P356
10.1111/VOX.12417
P577
2016-06-01T00:00:00Z